Quality of life in patients with cerebral palsy: literature review

Currently, much attention is paid to the study of the quality of life of patients suffering from chronic pathology. The quality of life is closely related to the patient’s awareness of confidence and well–being in many areas, not only with the perception of their physical condition, but also in many other aspects of life including social interactions, emotional experiences, spiritual values and in other areas. Cerebral palsy is a severe chronic disabling disease with the presence of not only motor disorders, but also speech, cognitive, mental health problems that lead to social maladaptation. There are special tools for quality of life assessment, which include various questionnaires. Some of them, for example, the Pediatric Quality of Life Inventory (PedsQL) has a special module “Cerebral palsy”, the following problems are covered: daily activities, movement and balance, pain, fatigue, eating. From the age of 5 years, the block «speech and communication», «school classes» is added. Such questionnaires allow assessing quality of life disturbances by cerebral palsy and use these data for dynamic observation during the treatment. The article presents the most objective studies of the quality of life with cerebral palsy. Pain in patients with cerebral palsy is a serious problem and has a significant negative impact on the quality of life. It has been shown that injections of botulinum toxin type A can not only lead to pain reduction, but significantly improve the functioning of patients with cerebral palsy and improve their quality of life. It is equally important to assess the quality of life of parents and relatives of sick children. There is evidence that severe motor disorders by cerebral palsy have a significant negative impact on the quality of life and the development of depression by mothers who take care of a child.

Contribution:
Nezhelskaya A.A. — сoncept and design of the study, writing the text, editing;
Kurenkov A.L. — сoncept and design of the study, writing the text, editing;
Kuzenkova L.M. — editing;
Bursagova B.I. — writing the text.
All coauthors — approval of the final version of the article, responsibility for the integrity of all parts of the article.

Acknowledgments. The study had no sponsorship.

Conflict of interest. The authors declare no conflict of interest.

Received: August 25, 2022
Accepted: September 12, 2022
Published: September 30, 2022

1. WHOQOL: Measuring the quality of life. Available at: https://www.who.int/tools/whoqol

2. Karimullin G.A., Levitina E.V., Zmanovskaya V.A. Quality of life of children with cerebral palsy. Universitetskaya meditsina Urala. 2021; 4. (in Russian)

3. Denisova R.V. The quality of life of patients with juvenile arthritis under treatment with chimeric monoclonal antibodies to TNF: Diss. Moscow; 2009. (in Russian)

4. Vinyarskaya I.V. The quality of life of children as a criterion for assessing the state of health and effectiveness of medical technologies (comprehensive medical and social research): Diss. Moscow; 2008. (in Russian)

5. Kukhtina E.I. Quality of life of disabled children with cerebral palsy: Diss. Ufa; 2006. (in Russian)

6. Bjornson K.F., McLaughlin J.F. The measurement of health-related quality of life (HRQL) in children with cerebral palsy. Eur. J. Neurol. 2001; 8(Suppl. 5): 183–93. https://doi.org/10.1046/j.1468-1331.2001.00051.x

7. Varni J.W., Seid M., Rode C.A. The PedsQL: measurement model for the pediatric quality of life inventory. Med. Care. 1999; 37(2): 126–39. https://doi.org/10.1097/00005650-199902000-00003

8. Manificat S., Dazord A., Langue J., Danjou G., Bauche P., Bovet F., et al. Evaluation of the quality of life of infants and very young children: validation of a questionnaire. Multicenter European study. Arch. Pediatr. 2000; 7(6): 605–14. https://doi.org/10.1016/s0929-693x(00)80127-x (in French)

9. Riley A.W., Forrest C.B., Rebok G.W., Starfield B., Green B.F., Robertson J.A., et al. The Child Report Form of the CHIP-Child Edition: reliability and validity. Med. Care. 2004; 42(3): 221–31. https://doi.org/10.1097/01.mlr.0000114910.46921.73

10. Riley A.W., Forrest C.B., Starfield B., Rebok G.W., Robertson J.A., Green B.F. The Parent Report Form of the CHIP-Child Edition: reliability and validity. Med. Care. 2004; 42(3): 210–20. https://doi.org/10.1097/01.mlr.0000114909.33878.ca

11. Manificat S., Dazord A., Langue J., Danjou G., Bauche P., Bovet F., et al. Evaluation of the quality of life of infants and very young children: validation of a questionnaire. Multicenter European study. Arch. Pediatr. 2000; 7(6): 605–14. https://doi.org/10.1016/s0929-693x(00)80127-x

12. Chernikov V.V. Development and evaluation of the effectiveness of the Russian version of the QUALIN questionnaire for studying the quality of life of young children. Voprosy sovremennoy pediatrii. 2009; 8(1): 14–8. (in Russian)

13. Varni J.W., Burwinkle T.M., Berrin S.J. The PedsQL in pediatric cerebral palsy: reliability, validity, and sensitivity of the generic core scales and cerebral palsy module. Dev. Med. Child Neurol. 2006; 48(6): 442–29. https://doi.org/10.1017/s001216220600096x

14. Wake M., Salmon L., Reddihough D. Health status of Australian children with mild to severe cerebral palsy: cross-sectional survey using the child health questionnaire. Dev. Med. Child Neurol. 2003; 45(3): 194–9. https://doi.org/10.1017/s0012162203000379

15. McCormick A. Quality of life. In: Panteliadis C.P., ed. Cerebral Palsy: Multidisciplinary Approach. Cham: Springer; 2018: 335–42.

16. Colver A., Rapp M., Eisemann N., Ehlinger V., Thyen U., Dickinson H.O., et al. Self-reported quality of life of adolescents with cerebral palsy: a cross-sectional and longitudinal analysis. Lancet. 2015; 385(9969): 705–16. https://doi.org/10.1016/S0140-6736(14)61229-0

17. Kulishova T.V., Eliseev V.V., Lobanov Yu.F. Life quality as the criterion of complex treatment efficacy for patients with cerebral palsy in the form of spastic diplegia. Dal’nevostochnyy meditsinskiy zhurnal. 2016; (1): 47–9. (in Russian)

18. Vinkel M.N., Rackauskaite G., Finnerup N.B. Classification of pain in children with cerebral palsy. Dev. Med. Child. Neurol. 2022; 64(4): 447–52. https://doi.org/10.1111/dmcn.15102

19. Penner M., Xie W.Y., Binepal N., Switzer L., Fehlings D. Characteristics of pain in children and youth with cerebral palsy. Pediatrics. 2013; 132(2): e407–13. https://doi.org/10.1542/peds.2013-0224

20. Eriksson E., Hägglund G., Alriksson-Schmidt A.I. Pain in children and adolescents with cerebral palsy - a cross-sectional register study of 3545 individuals. BMC Neurol. 2020; 20(1): 15. https://doi.org/10.1186/s12883-019-1597-7

21. Parkinson K.N., Dickinson H.O., Arnaud C., Lyons A., Colver A. Pain in young people aged 13 to 17 years with cerebral palsy: cross-sectional, multicenter European study. Arch. Dis. Child. 2013; 98(6): 434–40. https://doi.org/10.1136/archdischild-2012-303482

22. Alriksson-Schmidt A., Hagglund G. Pain in children and adolescents with cerebral palsy: a population-based registry study. Acta Paediatr. 2016; 105(6): 665–70. https://doi.org/10.1111/apa.13368

23. Komshina K.S., Antipenko E.A. Evaluation of the features of pain syndrome in adult patients with cerebral palsy. Meditsinskiy al’manakh. 2020; (1): 73–7. (in Russian)

24. Multani I., Manji J., Hastings-Ison T., Khot A., Graham K. Botulinum toxin in the management of children with cerebral palsy. Paediatr. Drugs. 2019; 21(4): 261–81. https://doi.org/10.1007/s40272-019-00344-8

25. Simpson D.M., Hallett M., Ashman E.J., Comella C.L., Green M.W., Gronseth G.S., et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016; 86(19): 1818–26. https://doi.org/10.1212/WNL.0000000000002560

26. Copeland L., Edwards P., Thorley M., Donaghey S., Gascoigne-Pees L., Kentish M., et al. Botulinum toxin a for nonambulatory children with cerebral palsy: A double blind randomized controlled trial. J. Pediatr. 2014; 165(1): 140–6. https://doi.org/10.1016/j.jpeds.2014.01.050

27. Barwood S., Baillieu C., Boyd R., Brereton K., Low J., Nattrass G., et al. Analgesic effects of botulinum toxin A: A randomized, placebo-controlled clinical trial. Dev. Med. Child Neurol. 2000; 42(2): 116–21. https://doi.org/10.1017/S0012162200000220

28. Tilton A., Russman B., Aydin R., Dincer U., Escobar R., Kutlay S., et al. AbobotulinumtoxinA (Dysport®) improves function according to goal attainment in children with dynamic equinus due to cerebral palsy. J. Child Neurol. 2017; 32(5): 482–7. https://doi.org/10.1177/0883073816686910

29. Russo R.N., Crotty M., Miller M.D., Murchland S., Flett P., Haan E. Upper-limb botulinum toxin a injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: A single-blind, randomized, controlled trial. Pediatrics. 2007; 119(5): e1149–58. https://doi.org/10.1542/peds.2006-2425

30. Lundy C.T., Doherty G.M., Fairhurst C.B. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy. Dev. Med. Child Neurol. 2009; 51(9): 705–10. https://doi.org/10.1111/j.1469-8749.2009.03315.x

31. Vles G.F., de Louw A.J., Speth L.A., van Rhijn L.W., Janssen-Potten Y.J., Hendriksen J.G., et al. Visual analogue scale to score the effects of botulinum toxin a treatment in children with cerebral palsy in daily clinical practice. Eur. J. Paediatr. Neurol. 2008; 12(3): 231–8. https://doi.org/10.1016/j.ejpn.2007.08.002

32. Rivard P.F., Nugent A.C., Symons F.J. Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy. Clin. J. Pain. 2009; 25(5): 413–7. https://doi.org/10.1097/AJP.0b013e31819a6d07

33. Kingsnorth S., Orava T., Provvidenza C., Adler E., Ami N., Gresley-Jones T., et al. Chronic pain assessment tools for cerebral palsy: A systematic review. Pediatrics. 2015; 136(4): e947–60. https://doi.org/10.1542/peds.2015-0273

34. Jog M., Wein T., Bhogal M., Dhani S., Miller R., Ismail F., et al. Real-World, long-germ Quality of life following therapeutic Onabo­tulinumtoxinA treatment. Can. J. Neurol. Sci. 2016; 43(5): 687–96. https://doi.org/10.1017/cjn.2016.262

35. Wong С., Westphall I., Michelsen J.S. Measuring effects on pain and quality of life after AbobotulinumtoxinA injections in children with cerebral palsy. Toxins (Basel). 2022; 14(1): 43. https://doi.org/10.3390/toxins14010043

36. Boyer E.R., Novaczyk Z.B., Novacheck T.F., Symons F.J., Burkitt C.C. Presence and predictors of pain after orthopedic surgery and associated orthopedic outcomes in children with cerebral palsy. Paediatr. Neonatal. Pain. 2021; 4(1): 44–52. https://doi.org/10.1002/pne2.12067

37. Guinet A.L., Khouri N., Desailly E. Rehabilitation after single-event multilevel surgery for children and young adults with cerebral palsy: A systematic review. Am. J. Phys. Med. Rehabil. 2022; 101(4): 389–99. https://doi.org/10.1097/PHM.0000000000001864

38. Riva A., Amadori E., Vari M.S., Spalice A., Belcastro V., Viri M., et al. Impact and management of drooling in children with neurological disorders: an Italian Delphi consensus. Ital. J. Pediatr. 2022; 48(1): 118. https://doi.org/10.1186/s13052-022-01312-8

39. Sonune S.P., Gaur A.K., Shenoy A. Prevalence of depression and quality of life in primary caregiver of children with cerebral palsy. J. Family Med. Prim. Care. 2021; 10(11): 4205–11. https://doi.org/10.4103/jfmpc.jfmpc.70.21